These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31774327)

  • 41. Exacerbation of systemic lupus erythematosus induced by terbinafine.
    Holmes S; Kemmett D
    Br J Dermatol; 1998 Dec; 139(6):1133. PubMed ID: 9990401
    [No Abstract]   [Full Text] [Related]  

  • 42. Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases.
    Callen JP; Hughes AP; Kulp-Shorten C
    Arch Dermatol; 2001 Sep; 137(9):1196-8. PubMed ID: 11559217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Terbinafine-induced lupus erythematosus.
    Murphy M; Barnes L
    Br J Dermatol; 1998 Apr; 138(4):708-9. PubMed ID: 9640387
    [No Abstract]   [Full Text] [Related]  

  • 44. Drug-induced cutaneous lupus erythematosus: 88 new cases.
    Laurinaviciene R; Sandholdt LH; Bygum A
    Eur J Dermatol; 2017 Feb; 27(1):28-33. PubMed ID: 27799135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cutaneous lupus erythematosus induced by terbinafine].
    Møller M; Bygum A
    Ugeskr Laeger; 2006 Dec; 168(50):4427-8. PubMed ID: 17217873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug-induced cutaneous lupus erythematosus after 5 years of treatment with carbamazepine.
    Amerio P; Innocente C; Feliciani C; Angelucci D; Gambi D; Tulli A
    Eur J Dermatol; 2006; 16(3):281-3. PubMed ID: 16709494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of clinical characteristics of drug-induced cutaneous lupus erythematosus in men.
    Petty AJ; Cardones AR; Marano AL
    J Am Acad Dermatol; 2020 Nov; 83(5):1455-1457. PubMed ID: 32151631
    [No Abstract]   [Full Text] [Related]  

  • 48. Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature.
    Shakhbazova A; Marsch AF
    Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subacute cutaneous lupus erythematosus-like drug eruption due to combination diuretic hydrochlorothiazide and triamterene.
    Darken M; McBurney EI
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 1):38-42. PubMed ID: 3346407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lamotrigine induced subacute cutaneous lupus erythematous.
    Cabanillas M; Suárez-Amor O; Ramírez-Santos A; González-Vilas D; Núñez-Acevedo B; Monteagudo B; de las Heras C
    Dermatol Online J; 2012 Aug; 18(8):12. PubMed ID: 22948062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Thalidomide therapy of cutaneous lupus erythematosus].
    Bohmeyer J; Achenbach A; Westenberger M; Stadler R
    Hautarzt; 2002 Nov; 53(11):744-8. PubMed ID: 12402138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Issues and advances in the management and pathogenesis of cutaneous lupus erythematosus.
    Pelle MT
    Adv Dermatol; 2006; 22():55-65. PubMed ID: 17249295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cutaneous drug-induced lupus erythematosus: Clinical and immunological characteristics and update on new associated drugs.
    Bataille P; Chasset F; Monfort JB; De Risi-Pugliese T; Soria A; Francès C; Barbaud A; Senet P
    Ann Dermatol Venereol; 2021 Dec; 148(4):211-220. PubMed ID: 34711400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Capecitabine-induced subacute cutaneous lupus: a case report].
    Fongue J; Meunier B; Lardet D; Dicostanzo MP; Rouby F; Terrier JP; Harlé JR; Richard MA; Chiche L
    Ann Dermatol Venereol; 2014 Oct; 141(10):593-7. PubMed ID: 25288062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Drug-induced lupus erythematosus tumidus during treatment with adalimumab].
    Sohl S; Renner R; Winter U; Bodendorf M; Paasch U; Simon JC; Treudler R
    Hautarzt; 2009 Oct; 60(10):826-9. PubMed ID: 19229504
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug-induced Subacute Cutaneous Lupus Erythematosus Caused by a Topical Beta Blocker - Timolol.
    Bilewicz-Stebel M; Miziołek B; Bergler-Czop B; Stańkowska A
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):44-47. PubMed ID: 29782299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Subacute cutaneous lupus erythematosus induced by terbinafine].
    Amitay-Layish I; Feuerman H; David M
    Harefuah; 2006 Jul; 145(7):480-2, 552. PubMed ID: 16900733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cutaneous lupus associated with pembrolizumab therapy for advanced melanoma: a report of three cases.
    Blakeway EA; Elshimy N; Muinonen-Martin A; Marples M; Mathew B; Mitra A
    Melanoma Res; 2019 Jun; 29(3):338-341. PubMed ID: 30762712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A systematic review of drug-induced subacute cutaneous lupus erythematosus.
    Lowe GC; Henderson CL; Grau RH; Hansen CB; Sontheimer RD
    Br J Dermatol; 2011 Mar; 164(3):465-72. PubMed ID: 21039412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation.
    Sontheimer RD; Henderson CL; Grau RH
    Arch Dermatol Res; 2009 Jan; 301(1):65-70. PubMed ID: 18797894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.